Skip to main content
DYN filings

Corporate insider profile

Douglas Kerr Filing Activity

Latest reported as Chief Medical Officer of Dyne Therapeutics, Inc. (DYN).

Purchase filings
0
Reported companies
1
Net open-market value
-$44,973.75
Latest transaction
Jun 16, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 16, 2026Dyne Therapeutics, Inc. (DYN)Chief Medical OfficerSale887$18.33$16,259
May 13, 2026Dyne Therapeutics, Inc. (DYN)Chief Medical OfficerSale1,564$18.36$28,715